Medication Information


The Pharmacists at Carnegie Sargents Pharmacy dispense prescription medications to patients and offer expertise in the safe use of prescriptions. We work directly with physicians, other health professionals, and patients to ensure that the medications prescribed for patients contribute to the best possible health outcomes. We will provide you with the information you need to make knowledgeable decisions. We will also take the time to discuss with you how to interpret the information in order to have an intelligent conversation with you doctors. Our pharmacists possess in-depth knowledge of medications that is integrated with a foundational understanding of the biomedical, pharmaceutical, sociobehavioral, and clinical sciences. To achieve desired therapeutic goals, our pharmacists apply evidence-based therapeutic guidelines, evolving sciences, emerging technologies, and relevant legal, ethical, social, cultural, economic and professional principles. All information provided is for educational purposes only and is not intended to replace your doctor(s) or guide individual patient care in any manner. Our objective is to improve the quality of care and decrease hospitalizations

Take This Survey and We Will Let You Know

Complete the form and then click the boxes to indicate the type of information you'd like to receive.

First Name (required)

Last Name

Email (required)

Phone Number

Medication/Product Name


Pronunciation - Phonetic Pronunciation Guide
Index Terms - Other names or accepted abbreviations of the generic drug
Dosage Forms - Information with regard to form, strength, and availability of the drug in the United States. Note: Additional formulation information (eg, excipients, preservatives) is included when available. Please consult product labeling for further information.
Pharmacologic Category - Unique systematic classification of medications

Pharmacology - How the drug works in the body to elicit a response
Pharmacokinetics/Dynamics - The magnitude of a drug's effect depends on the drug concentration at the site of action. The pharmacodynamics are expressed in terms of onset of action and duration of action. Pharmacokinetics are expressed in terms of absorption, distribution (including appearance in breast milk and crossing of the placenta), protein binding, metabolism, half-life distribution, time to peak, and excretion.
Pharmacology - How the drug works in the body to elicit a response
Special Populations - Describes pharmacokinetic/dynamic information unique to certain patient populations. May include informaton based on Renal Function Impairment, Hepatic Function Impairment, Age, Gender, and Race.

Use: Labeled Indications - Information pertaining to FDA- or Canadian-approved indications for the drug
Use: Unlabeled - Information pertaining to unlabeled or investigational indications of the drug


Administration and Dosage
Dosage - The amount of the drug to be typically given or taken during therapy for children and adults; also includes any dosing adjustments/comments for renal impairment or hepatic impairment and other suggested dosing adjustments (eg, hematological toxicity).
Reconstitution - Information regarding reconstitution guidance (when necessary
Extemporaneously Prepared - Directions for preparing liquid formulations from solid drug products. May include stability information and references.
Administration - Information regarding the recommended final concentrations, rates of administration for parenteral drugs, or other guidelines when giving the medication
Dietary Considerations - Specific dietary modifications and/or restrictions
Storage - Includes compatibility information, when available, for admixtures, Y-site administration, and syringe storage.
Use: Labeled Indications - Information regarding storageof product.. Provides the time and conditions for which a solution or mixture will maintain full potency. For example, some solutions may require refrigeration after reconstitution while stored at room temperature prior to preparation.

Drug Interactions - This field presents a description of the interaction between the drug listed in the monograph and other drugs or drug classes. Following a description of the interaction for a drug class, any drugs from that class which are NOT likely to cause a similar interaction with the monograph drug are listed as exceptions. Lastly, the significance of the interaction is identified as follows: Monitor therapy – data demonstrate that the specified agents may interact with each other in a clinically-significant manner, but the benefits of concomitant use usually outweigh any risks. An appropriate monitoring plan should be implemented to identify potential negative effects and dosage adjustments may be needed in a minority of patients. Consider therapy modification - data demonstrate that the specified agents may interact with each other in a clinically-significant manner and patient-specific assessment must be conducted to determine whether the benefits of concomitant therapy outweigh the risks. Specific actions must be taken in order to realize the benefits and/or minimize toxicity of concomitant use. Avoid combination - data demonstrate that the specified agents may interact with each other in a clinically-significant manner and the risk generally outweighs any potential benefit. Concurrent use of these agents is generally considered contraindicated.
Test Interactions - Listing of assay interferences when relevant

Adverse Reactions

ALERT: U.S. Boxed Warning - The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information. For verbatim wording of the boxed warning, consult the product labeling or
Warnings/Precautions - Precautionary considerations, hazardous conditions related to use of the drug, and disease states or patient populations in which the drug should be cautiously used. Boxed warnings, when present, are clearly identified and are adapted from the FDA-approved labeling. Consult the product labeling for the exact black box warning through the manufacturer's or the FDA websites.
Monitoring Parameters - Laboratory tests and patient physical parameters that should be monitored for safety and efficacy of drug therapy
Pregnancy Risk Factor - Five categories established by the FDA to indicate the potential of a systemically absorbed drug for causing risk to the fetus
Pregnancy Considerations - A summary of human and/or animal information pertinent to or associated with the use of the drug as it relates to clinical effects on the fetus, newborn, or pregnant woman
Lactation - Indicates if the drug listed in the monograph is present in breast milk and the manufacturer's recommendation for use while breast-feeding (when recommendation of American Academy of Pediatrics differs, notation is made)
Patient Education - Specific information pertinent for the patient

Boxed Warning

Don't Crush/Chew

Lab Values / Body Measurements

Manufacture Index

Medication Safety Programs / REMS (Risk Evaluation and Mitigation Strategy)

Off-Label Drug Facts

Patient Assistance Programs

Patient Hand-Outs

Pregnancy and Lactation Warnings

Review of Natural Products

Drug Identifier
Drug Interactions
Drug Search by Disease/Symptom
- Find out what a drug is used for, or if an adverse reaction may be caused by a certain drug.

* Information provided by Wolters Kluwer Clinical Drug Information.

Wolters Kluwer had a strategic vision leading to the acquisition of top drug information applications Lexicomp, Medi-Span, and Facts & Comparisons. All three applications were developed with a mission of delivering timely, relevant, rigorously reviewed, and unbiased drug and clinical information in the most cutting-edge platforms, but without sacrificing ease of use. While each line has a distinct character, together they form a complete medication decision support solution, serving a wide array of healthcare markets and offering consistent content and aligned solutions encompassing both drug reference and drug data.